Search
14/09/2022
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254
Spinner, CD, Felizarta, F, Rizzardini, G, Philibert, P, Mitha, E, Domingo, P, Stephan, CJ, DeGrosky, M, Bainbridge, V, Zhan, J, Dumitrescu, TP, Jeffrey, JL, Xu, JF, Halliday, F, Gan, JJ, Johnson, M, Gartland, M, Joshi, SR, Lataillade, M. Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254. CLINICAL INFECTIOUS DISEASES. 2022; 75(5)DOI:10.1093/cid/ciab1065. PMID:34996113. IF:11.800(Q1/1D).
12/09/2022
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain
Majem, M, Alvarez, R, Ortega, AL, de Alda, LR, Gordo, R, Garcia, JF, Ivanova-Markova, Y, Gonzalez-Dominguez, A, San Cristobal, RS, Rojo, F. Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain. Global & Regional Health Technology Assessment. 2022; 9DOI:10.33393/grhta.2022.2449. PMID:36628311. IF:(Q/D).
10/09/2022
Tackling health inequalities in a public health organization: the case of the Barcelona Public Health Agency
Perez, G, Pasarin, MI, Puig-Barrachina, V, Perez, K, Rodriguez-Sanz, M, Artazcoz, L, Borrell, C. Tackling health inequalities in a public health organization: the case of the Barcelona Public Health Agency. International Journal for Equity in Health. 2022; 21(1)DOI:10.1186/s12939-022-01724-2. PMID:36088347. IF:4.800(Q1/2D).
09/09/2022
Predictors and changes of physical activity in idiopathic pulmonary fibrosis
Badenes-Bonet, D, Rodo-Pin, A, Castillo-Villegas, D, Vicens-Zygmunt, V, Bermudo, G, Hernandez-Gonzalez, F, Portillo, K, Martinez-Llorens, J, Chalela, R, Caguana, O, Sellares, J, Molina-Molina, M, Duran, X, Gea, J, Rodriguez-Chiaradia, DA, Balcells, E. Predictors and changes of physical activity in idiopathic pulmonary fibrosis. BMC Pulmonary Medicine. 2022; 22(1)DOI:10.1186/s12890-022-02134-4. PMID:36085057. IF:3.100(Q3/7D).
06/09/2022
Early Motor Changes in Genetic Frontotemporal Dementia
Lleo, A, Illan-Gala, I. Early Motor Changes in Genetic Frontotemporal Dementia. NEUROLOGY. 2022; 99(10)DOI:10.1212/WNL.0000000000200967. PMID:36219793. IF:9.900(Q1/1D).
05/09/2022
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI
Vogel, RF, Delewi, R, Badimon, L, Angiolillo, DJ, Vlachojannis, GJ. Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI. Reviews in Cardiovascular Medicine. 2022; 23(9)DOI:10.31083/j.rcm2309297. PMID:. IF:2.700(Q3/6D).
05/09/2022
Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
Unzueta, U, Sanchez, JM, Garcia-Fruitos, E, Seras-Franzoso, J. Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste. Frontiers in Bioengineering and Biotechnology. 2022; 10DOI:10.3389/fbioe.2022.1018014. PMID:36131721. IF:5.700(Q1/3D).
03/09/2022
Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease
Benejam, B, Aranha, MR, Videla, L, Padilla, C, Valldeneu, S, Fernandez, S, Altuna, M, Carmona-Iragui, M, Barroeta, I, Iulita, MF, Montal, V, Pegueroles, J, Bejanin, A, Gimenez, S, Gonzalez-Ortiz, S, Videla, S, Bartres-Faz, D, Alcolea, D, Blesa, R, Lleo, A, Fortea, J. Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01064-x. PMID:36057615. IF:9.000(Q1/1D).